ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
New Jersey-based Dr Reddy's Laboratories, Inc initiated the Class III recall on November 21 this year. As per USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health
Announcement as on 04 December 2022

Dr Reddy's Laboratories among other generic pharma companies in US to face antitrust litigation
"The complaint, which purports to be on behalf of a class of indirect purchasers, asserts claims under federal and state antitrust laws and other state laws alleging that the defendants improperly restrained competition and maintained a shared monopoly in
Announcement as on 22 November 2022

Inflows in Tata Motors stock may surge as it replace Dr Reddy's in Sensex
Change effective from Dec 19, but adjustment will take place on Dec 16. After DRL's deletion, Sun Pharma will be the only healthcare stock in the index
Announcement as on 18 November 2022

Dr Reddy's lines up Rs 1,500 cr capex, to focus on biosimilars, injectables
Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses, according to CFO Parag Agarwal. The Hyderabad-based drug major also pl
Announcement as on 06 November 2022

Dr Reddy's Labs lines up Rs 1,500 crore capex with focus on biosimilars, injectables
Elaborating on the overall strategies, Dr Reddy's Laboratories CEO Erez Israeli said the company's R&D is focusing on creating "as much as possible on differentiated products, on biosimilars, on products that have bigger potential."
Announcement as on 06 November 2022

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.89
  • 12Day Average: 13.69
  • 20Day Average: 13.96
  • 50Day Average: 13.59
  • 100Day Average: 13.68
  • 150Day Average: 13.73
  • 200Day Average: 13.8

RDY Indicators & signals

Indicator MACD (12,26,9)

13.45, 13.66, 0.01
Indicator MACD is in negative zone

Indicator ADX (14)

36, 20.51, 43.59
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Thu Jul 2026 12.70 12.66 to 12.85 -0.55% 0.61 times
15 Wed Jul 2026 12.77 12.75 to 12.95 -0.55% 0.68 times
14 Tue Jul 2026 12.84 12.70 to 12.95 -0.62% 0.92 times
13 Mon Jul 2026 12.92 12.92 to 13.27 -2.12% 0.79 times
10 Fri Jul 2026 13.20 13.06 to 13.70 -4.97% 0.95 times
09 Thu Jul 2026 13.89 13.57 to 14.06 -1.63% 1.69 times
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.43 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 1 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.44 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.8 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.3 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1.24 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top